[1]
M. Rosas-Peralta, “Beyond Mineralocorticoid Receptor Blockade: Aldosterone Synthase Inhibition as a New Therapeutic Frontier in the Cardiovascular–Kidney–Metabolic Era-What is really new?”, Ann Clin Hypertens, pp. 52–64, Nov. 2026.